Health Affairs August 25, 2023
Troyen A. Brennan, William H. Shrank

So rare is bipartisan regulatory legislation in Congress, especially in health care, that when it occurs one must presume it is in response to prohibitive costs to society or a threat to patient welfare. Pharmacy benefit managers (PBMs) seem to be considered both, as no fewer than eight separate bills to change PBM practices have recently been introduced or advanced out of committee, all of them involving both Democratic and Republican co-sponsors. This remarkable collaboration, following on the heels of the historic, and decidedly partisan, decision to allow the Centers for Medicare and Medicaid Services (CMS) to negotiate medication prices, deserves careful policy analysis.

Pharmacy Benefit Management Tools And Strategies

PBMs are a relatively new addition to the health policy...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Regulations
Medicare's $2K drug cap starts Jan. 1
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans

Share This Article